AFP and neoplasm: At the stage of intermediate follow-up (3-6 months), attention is turned to detailed tumor assessment, it involves Imaging: MRI or CT every three months for the first six months, monitoring Tumor markers, AFP, CEA, or CA19-9, depending on the type of malignancy [10].